Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses mitigating racial disparities in myeloproliferative neoplasm (MPN) clinical trials.
Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses mitigating racial disparities in myeloproliferative neoplasm (MPN) clinical trials.